Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ALHCNASDAQ:HCMNYSE:HNGRNASDAQ:IMAC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALHCAlignment Healthcare$14.94-0.9%$16.37$7.05▼$21.06$2.96B1.222.04 million shs1.58 million shsHCMHUTCHMED$16.90-4.6%$14.35$11.51▼$21.50$2.95B0.5299,837 shs159,752 shsHNGRHanger$18.72$18.70$13.42▼$22.67$732.38M1.28356,429 shsN/AIMACIMAC$0.04-12.9%$0.04$0.75▼$1.65$26.75M-0.88708,132 shs18,288 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALHCAlignment Healthcare-0.93%-1.84%+0.20%-5.38%+84.44%HCMHUTCHMED-4.63%+10.10%+27.07%+7.71%-5.69%HNGRHanger0.00%0.00%0.00%0.00%0.00%IMACIMAC-2.44%-2.44%+26.58%-92.97%-98.58%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALHCAlignment Healthcare1.4606 of 5 stars2.32.00.00.01.92.50.6HCMHUTCHMED1.4542 of 5 stars2.02.00.00.02.80.01.9HNGRHangerN/AN/AN/AN/AN/AN/AN/AN/AIMACIMACN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALHCAlignment Healthcare 2.64Moderate Buy$17.1714.90% UpsideHCMHUTCHMED 2.00Hold$19.0012.43% UpsideHNGRHanger 0.00N/AN/AN/AIMACIMAC 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HNGR, IMAC, HCM, and ALHC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025ALHCAlignment HealthcareStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/13/2025HCMHUTCHMEDHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold5/2/2025ALHCAlignment HealthcareUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$16.00 ➝ $17.004/15/2025ALHCAlignment HealthcareRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$17.00 ➝ $22.004/8/2025ALHCAlignment HealthcareStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $23.00(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALHCAlignment Healthcare$3.00B0.98N/AN/A$0.84 per share17.79HCMHUTCHMED$630.20M4.67$0.69 per share24.51$4.27 per share3.96HNGRHanger$1.12B0.65$1.88 per share9.98$2.85 per share6.57IMACIMAC$15.22M0.07N/AN/A$0.69 per share0.06Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALHCAlignment Healthcare-$148.02M-$0.48N/AN/AN/A-5.84%-108.69%-21.89%7/30/2025 (Estimated)HCMHUTCHMED$100.78MN/A0.0011.58N/AN/AN/AN/A6/18/2025 (Estimated)HNGRHanger$41.98M$0.9519.7115.60N/A3.17%35.72%4.00%N/AIMACIMAC-$10.54MN/A0.00N/AN/A-75.40%-52.17%-34.51%N/ALatest HNGR, IMAC, HCM, and ALHC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025ALHCAlignment Healthcare-$0.12-$0.05+$0.07-$0.05$889.83 million$926.93 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALHCAlignment HealthcareN/AN/AN/AN/AN/AHCMHUTCHMEDN/AN/AN/AN/AN/AHNGRHangerN/AN/AN/AN/AN/AIMACIMACN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALHCAlignment Healthcare1.821.601.60HCMHUTCHMED0.072.812.68HNGRHanger3.711.230.85IMACIMAC0.011.271.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALHCAlignment Healthcare86.19%HCMHUTCHMED8.82%HNGRHanger79.17%IMACIMAC24.27%Insider OwnershipCompanyInsider OwnershipALHCAlignment Healthcare7.00%HCMHUTCHMED3.60%HNGRHanger4.36%IMACIMAC10.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALHCAlignment Healthcare850197.84 million179.04 millionOptionableHCMHUTCHMED1,760174.32 million168.04 millionNot OptionableHNGRHanger5,20039.12 million37.42 millionOptionableIMACIMAC10626.49 million23.84 millionNot OptionableHNGR, IMAC, HCM, and ALHC HeadlinesRecent News About These CompaniesWhat’s next for Mac? Here’s what I predict is coming to the Mac line-upJune 13 at 11:11 AM | msn.comApple just supercharged MacBook & iMac: Liquid Glass macOS 26 Tahoe revealed at WWDC 2025; check details hereJune 10, 2025 | fortuneindia.comIMAC Holdings Appoints New Board Members for Strategic GrowthJune 6, 2025 | tipranks.comHistory of the eMacJune 6, 2025 | msn.comIMAC Holdings Issues Promissory Note for $455,000June 5, 2025 | tipranks.comGet the Apple 2024 iMac 24-inch (M4, 10-core CPU/10-core GPU, 16GB/256GB, Green) for $1,297.06 (originally $1,499.00) – $201.94 savingsJune 4, 2025 | msn.comApple's Upcoming macOS 26 Could Be Bad News For Owners Of Older ModelsJune 4, 2025 | msn.comIt’s time for Apple to re-introduce this long discontinued macOS featureJune 2, 2025 | 9to5mac.commacOS 26 may not support these four Mac models: Is yours on the list?May 30, 2025 | msn.comWhen are new Macs coming? Here’s the latestMay 29, 2025 | 9to5mac.comRumor: macOS 26 may not support some more recent Macs including MacBook Air 2020 with Intel CPUMay 29, 2025 | tweaktown.commacOS 26 may drop support to these Intel Macs as Apple winds down transitionMay 29, 2025 | bgr.comThis Year’s ‘macOS 26’ Release May End Support for These MacsMay 29, 2025 | idropnews.comApple is reportedly dropping support for nearly every Intel Mac this yearMay 29, 2025 | msn.commacOS 26 may not support 2018 MacBook Pros, 2019 iMacs, or the iMac ProMay 29, 2025 | appleinsider.comWhy Apple Needs to Bring Back the iMac ProMay 26, 2025 | idropnews.comOpenAI recruits legendary iPhone designer Jony Ive to work on AI hardware in $6.5B dealMay 23, 2025 | msn.comiPhone designer Jony Ive teams up with ChatGPT creator OpenAI to make the device of the futureMay 23, 2025 | msn.comWho is Sir Jony Ive: The design icon behind the iPhone joins OpenAI’s hardware pushMay 22, 2025 | cnbctv18.comEarly Memorial Day Drop: Apple’s New M4 iMac Just Got Its First Price CutMay 21, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHNGR, IMAC, HCM, and ALHC Company DescriptionsAlignment Healthcare NASDAQ:ALHC$14.94 -0.14 (-0.93%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$15.25 +0.31 (+2.07%) As of 06/13/2025 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.HUTCHMED NASDAQ:HCM$16.90 -0.82 (-4.63%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$16.90 +0.01 (+0.03%) As of 06/13/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.Hanger NYSE:HNGRHanger, Inc. provides orthotic and prosthetic (O&P) services in the United States. It operates in two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and offers payor network contracting services to other O&P providers. The Products & Services segment engages in the distribution of various O&P parts, componentry, and devices to independent O&P providers; development of specialized rehabilitation technologies; and provision of evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of December 31, 2021, the company operated approximately 760 patient care clinics and 115 satellite locations in 47 states and the District of Columbia. It also distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.IMAC NASDAQ:IMAC$0.04 -0.01 (-12.85%) As of 06/12/2025IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
